Predicting CSA-AKI With ACTA-PORT Score | NCT06484907 | Trialant

Predicting CSA-AKI With ACTA-PORT Score | NCT06484907 | Trialant

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
KDIGO AKI Staging	KDIGO is in the process of developing the Clinical Practice Guideline for Acute Kidney Injury (AKI) and Acute Kidney Disease (AKD). ///// Stage 1: Serum creatinine 1.5-1.9 times baseline or ≥0.3 mg/dl (≥26.5 mmol/l) increase or Urine output <0.5 ml/kg/h for 6-12 hours ////// Stage 2: Serum creatinine 2.0-2.9 times baseline or <0.5 ml/kg/h for ≥12 hours /////// Stage 3: Serum creatinine 3.0 times baseline or Increase in serum creatinine to ≥4.0 mg/dl (≥353.6 mmol/l) or Initiation of renal replacement therapy or in patients <18 years, decrease in eGFR to <35 ml/min per 1.73 m² or Urine output <0.3 ml/kg/h for ≥24 hours or anuria for ≥12 hours	Preoperative (last week before operation) and daily after the operation for 7 days

Secondary Outcomes

Measure	Description	Time Frame
Mechanical Ventilation Duration	The duration the patient remains intubated from surgery to extubation	the duration after surgery up to a month
Intensive Care Duration	The duration the patient remains in intensive care unit after surgery

Contacts/Locations Module

Condition Browse Module